Novo Nordisk at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Novo Nordisk brings 1 presentation to ASH 2026 in New Orleans, and exhibits at Booth 913. Its presence centres on sickle cell disease, where it supports a symposium on genetic therapies, activators and other new options. It also offers advice on common obstacles facing early-career faculty.
| Organization | ASH 2026 Attendance |
|---|---|
Novo Nordisk Bagsværd, Denmark | |
Danish pharmaceutical company; its rare disease unit develops treatments for hemophilia and other rare blood disorders, including sickle cell disease. | Booth Exhibiting at Booth 913 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 7:00am–10:00am A Hematologist’s Guide to the Sickle Cell Disease Revolution: Genes, Activators, and Beyond Approved and emerging gene therapies and new pyruvate kinase activators for sickle cell disease, and how to match patients to each and refer them. |
Instantly find 20 buyers from Novo Nordisk
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction